ProstaGene Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$15.1M
ProstaGene General Information
Description
Developer of a diagnostic test designed to distinguish benign from malignant prostate cancer. The company's prognostic test technology defines a group of patients with poor outcomes based on a signature of gene expression in the patient's prostate tumor and it also offers a platform for preclinical testing of therapies for metastatic prostate cancer, enabling patients to early detect and cure cancers.
Contact Information
Website
www.prostagene.comCorporate Office
- 100 Lancaster Avenue
- Room 133
- Wynnewood, PA 19096
- United States
Corporate Office
- 100 Lancaster Avenue
- Room 133
- Wynnewood, PA 19096
- United States
ProstaGene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 16-Nov-2018 | $15.1M | Completed | Generating Revenue | ||
| 3. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 2. Later Stage VC | 17-Apr-2016 | $400K | $1.23M | Completed | Generating Revenue | |
| 1. Seed Round | 19-May-2015 | $825K | $825K | Completed | Generating Revenue |
ProstaGene Comparisons
Industry
Financing
Details
ProstaGene Competitors (37)
One of ProstaGene’s 37 competitors is Carina Biotech, a Venture Capital-Backed company based in Mawson Lakes, Australia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Carina Biotech | Venture Capital-Backed | Mawson Lakes, Australia | ||||
| TScan Therapeutics | Formerly VC-backed | Waltham, MA | ||||
| Aro Biotherapeutics | Venture Capital-Backed | Philadelphia, PA | ||||
| Geneos Therapeutics | Venture Capital-Backed | Philadelphia, PA | ||||
| Vyriad | Venture Capital-Backed | Rochester, MN |
ProstaGene Patents
ProstaGene Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2013262977-A1 | Using modulators of ccr5 for treating cancer | Inactive | 14-May-2012 | ||
| AU-2018201516-A1 | Using modulators of ccr5 for treating cancer | Inactive | 14-May-2012 | ||
| AU-2020200083-A1 | Using modulators of ccr5 for treating cancer | Inactive | 14-May-2012 | ||
| EP-2861302-A1 | Using modulators of ccr5 for treating cancer | Inactive | 14-May-2012 | ||
| EP-2861302-A4 | Using modulators of ccr5 for treating cancer | Inactive | 14-May-2012 | A61K31/506 |
ProstaGene Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Jefferson Accelerator Zone | Accelerator/Incubator | |||
| Angel (individual) | Minority | |||
| Thomas Jefferson University | University | Minority |
ProstaGene FAQs
-
When was ProstaGene founded?
ProstaGene was founded in 2010.
-
Where is ProstaGene headquartered?
ProstaGene is headquartered in Wynnewood, PA.
-
What industry is ProstaGene in?
ProstaGene’s primary industry is Diagnostic Equipment.
-
Is ProstaGene a private or public company?
ProstaGene is a Private company.
-
What is the current valuation of ProstaGene?
The current valuation of ProstaGene is .
-
What is ProstaGene’s current revenue?
The current revenue for ProstaGene is .
-
How much funding has ProstaGene raised over time?
ProstaGene has raised $1.23M.
-
Who are ProstaGene’s investors?
Jefferson Accelerator Zone, , and Thomas Jefferson University have invested in ProstaGene.
-
Who are ProstaGene’s competitors?
Carina Biotech, TScan Therapeutics, Aro Biotherapeutics, Geneos Therapeutics, and Vyriad are some of the 37 competitors of ProstaGene.
-
When was ProstaGene acquired?
ProstaGene was acquired on 16-Nov-2018.
-
Who acquired ProstaGene?
ProstaGene was acquired by Cytodyn.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process